button menu mobile
Philosophy
Portfolio
People
News
Contact
Home
Thinking
Delix Therapeutics Announces Positive Efficacy...
Delix Therapeutics...
Delix Therapeutics Announces Positive Efficacy Data for DLX-001 (Zalsupindole) and FDA Clearance of Phase II Trial Design Featuring At‑Home Administration
Share:
LinkedIn
Twitter/X